TD Cowen Initiates Coverage On Biodesix with Buy Rating, Announces Price Target of $2.8
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Dan Brennan initiates coverage on Biodesix (NASDAQ:BDSX) with a Buy rating and a price target of $2.8.
May 13, 2024 | 11:26 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen's initiation of coverage on Biodesix with a Buy rating and a price target of $2.8 could positively influence investor sentiment and potentially drive the stock price up in the short term.
Analyst ratings, especially from reputable firms like TD Cowen, can significantly impact stock prices. A Buy rating suggests a positive outlook on the stock, potentially leading to increased investor interest and a rise in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100